However, based on our previous observations that the CRP ASO decreased MDSC infiltration into I/R injured kidneys and that tumor challenged CRP−/− mice had decreased intra-tumor MDSCs, we predict that a CRP-specific ASO should decrease CRP-driven MDSC infiltration into tumors. Here, CRP is linked to neoplasm.